Guardian molecule keeps cells on track: New perspectives for the treatment of liver cancer
A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...
The Lancet49m
Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective
Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...
The American Journal of Managed Care5h
TILs May Guide Treatment De-Escalation in ERBB2-Positive Breast Cancer
A follow-up of the ShortHER trial suggests tumor-infiltrating lymphocytes (TILs) can help identify patients who may benefit ...
The EMBO Journal12h
Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4
Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...
The Lancet19h
Alcohol and cancer risk: bridging the awareness gap
Each year in the USA, alcohol use contributes to nearly 100 000 new cancer cases and 20 000 deaths from cancer, according to ...
American Cancer Society1d
RFA: Cancer Health Equity Research Centers
As part of the American Cancer Society (ACS) mission to promote fair and just opportunities for all people to prevent, detect, treat, and survive cancer, we’ve created the Cancer Health Equity ...